KSM Feed

Our collaboration in genetic research with the United Arab Emirates.

First collaboration in genetic research between Israel and the United Arab Emirates.

82% decreased risk of reinfection among persons who were infected and then vaccinated.

Association of BNT162b2 COVID-19 Vaccination During Pregnancy With Neonatal and Early Infant Outcomes.

Dr. Sivan Gazit, Deputy Head of KSM, was chosen by TheMarker as one of the most promising leaders under 40.

Short Term Reduction in the Odds of Testing Positive for SARS-CoV-2; a Comparison Between Two and Three doses of Vaccine.

Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections.

New collaboration with Ibex – introducing the world first AI powered solution for gastrointestinal cancer diagnosis at Maccabi Healthcare Services.

Our new study on COVID-19 vaccine effectiveness in patients with Inflammatory Bowel Disease (IBD).

Continuing to monitor vaccinated members – 62 days following the first vaccine dose.

Continuing to monitor vaccinated members. Coronavirus update February 18.

The safety and effectiveness of the COVID-19 vaccine on pregnant population.

Community-level evidence for SARS-CoV-2 vaccine protection of unvaccinated individuals.

Our new survey on behaviour attitudes towards preventive measures following Coronavirus vaccination.

The rate of children diagnosed with celiac in Israel has increased almost threefold over a decade.